30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jim Tyree

Track

Insider profile

Currently holds a position at ChemoCentryx Inc

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 41% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director ChemoCentryx Inc June 5, 2012 -
Independent Director Innoviva Inc June 2, 2014 - June 2, 2017
Jim Tyree's trades of Genelux Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-30 2024-12-30
US Genelux Corp (GNLX)
PrS Proposed sale
66,255
324.78
US$681,939 		66,255 324.78 US$681,939
2024-12-30 2024-12-30
US Genelux Corp (GNLX)
S Sale
30,360 -27.3%
106.72
US$1,315,775 		30,360 -27.3% 106.72 US$1,315,775
2024-09-12 2024-09-11
US Genelux Corp (GNLX)
PlS Planned sale
27,029 -10.7%
154.81
US$2,132,478 		27,029 -10.7% 154.81 US$2,132,478
2024-09-11 2024-09-11
US Genelux Corp (GNLX)
PrS Proposed sale
1,730
2.51
US$4,342 		1,730 2.51 US$4,342
2024-03-15 2024-03-14
S Sale
10,251 -5.2%
1.12
US$11,463 		10,251 -5.2% 1.12 US$11,463
2024-03-14 2024-03-14
PrS Proposed sale
10,251
1.12
US$11,463 		10,251 1.12 US$11,463
2023-12-14 2023-12-13
US Genelux Corp (GNLX)
S Sale
3,347 -49.2%
13.73
US$45,963 		3,347 -49.2% 13.73 US$45,963
2023-12-14 2023-12-13
US Genelux Corp (GNLX)
S Sale
5,653 -45.4%
12.91
US$73,006 		5,653 -45.4% 12.91 US$73,006
2023-12-13 2023-12-13
US Genelux Corp (GNLX)
PrS Proposed sale
9,000
13.22
US$118,969 		9,000 13.22 US$118,969
2023-05-05 2023-05-05
PrS Proposed sale
43,143
6.00
US$258,767 		43,143 6.00 US$258,767
2023-05-05 2023-05-05
PlS Planned sale
43,143 -20.5%
6.00
US$258,767 		43,143 -20.5% 6.00 US$258,767
2022-08-08 2022-08-04
PlS Planned sale
10,000 -52.3%
50.22
US$502,200 		10,000 -52.3% 50.22 US$502,200
2022-06-13 2022-06-09
PlS Planned sale
59 -0.3%
26.22
US$1,547 		59 -0.3% 26.22 US$1,547
2022-06-13 2022-06-09
PlS Planned sale
3,804 -16.5%
25.65
US$97,582 		3,804 -16.5% 25.65 US$97,582
2022-05-16 2022-05-12
PlS Planned sale
44,643 -17.5%
2.36
US$105,170 		44,643 -17.5% 2.36 US$105,170
2021-12-21 2021-12-17
PlS Planned sale
18,066 -54.2%
35.50
US$641,415 		18,066 -54.2% 35.50 US$641,415
2021-12-21 2021-12-17
PlS Planned sale
16,634 -33.3%
34.74
US$577,893 		16,634 -33.3% 34.74 US$577,893
2021-12-21 2021-12-17
PlS Planned sale
2,800 -5.3%
33.52
US$93,856 		2,800 -5.3% 33.52 US$93,856
2021-05-24 2021-05-21
PlS Planned sale
2,454 -13.8%
9.76
US$23,956 		2,454 -13.8% 9.76 US$23,956
2020-01-15 2020-01-13
PlS Planned sale
14,715 -73.4%
37.44
US$550,916 		14,715 -73.4% 37.44 US$550,916
2020-01-15 2020-01-13
PlS Planned sale
15,285 -43.2%
36.69
US$560,770 		15,285 -43.2% 36.69 US$560,770